Michael Winlo
Chief Executive Officer presso EMYRIA LIMITED
Patrimonio netto: 18 698 $ in data 31/03/2024
Profilo
Michael Winlo is the founder of Cerulean Medical Pty Ltd.
(founded in 2007).
He is currently the Chief Executive Officer, Director & MD at Emyria Ltd., a Non-Executive Director at dorsaVi Ltd.
(starting in 2023), a Director at Linear Clinical Research Ltd., and a Non-Executive Director at Nanoveu Ltd.
(starting in 2023).
Dr. Winlo has an MBA from Stanford University and an undergraduate degree from The University of Western Australia Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EMYRIA LTD
0.13% | 08/08/2023 | 485 794 ( 0.13% ) | 18 698 $ | 31/03/2024 |
Posizioni attive di Michael Winlo
| Società | Posizione | Inizio |
|---|---|---|
| EMYRIA LIMITED | Chief Executive Officer | 03/10/2019 |
| NANOVEU LIMITED | Director/Board Member | 28/03/2023 |
| DORSAVI LTD | Director/Board Member | 25/10/2023 |
| Linear Clinical Research Ltd. | Director/Board Member | 01/10/2019 |
Precedenti posizioni note di Michael Winlo
| Società | Posizione | Fine |
|---|---|---|
| Cerulean Medical Pty Ltd. | Founder | - |
Formazione di Michael Winlo
| Stanford University | Masters Business Admin |
| The University of Western Australia Business School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| DORSAVI LTD | Electronic Technology |
| NANOVEU LIMITED | Electronic Technology |
| EMYRIA LIMITED | Technology Services |
| Aziende private | 2 |
|---|---|
| Linear Clinical Research Ltd. | |
| Cerulean Medical Pty Ltd. | Health Technology |
- Borsa valori
- Insiders
- Michael Winlo
